滚动资讯
Thermo FisherHow Thermo Fisher’s Glacios 3 aims to broaden access to cryo-EM - R&D WorldThermo FisherLobbying Update: $21,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver QuantitativeFierceBiotechTakeda tears up Denali partnership, returning dementia asset amid restructuringFierceBiotechAI model designs new treatment candidate for opioid addiction that cuts cravings in ratsAgilentAgilent CLO Departing With Severance After Less Than 2 Years in Role - Law.comBioPharma DiveHims & Hers says limited data stolen in social engineering attackLonza NewsLonza Group AG stock: What investors should know about its biotech edge now - AD HOC NEWSBioPharma DiveUnder-the-skin Tepezza comparable to infused version in key study, Amgen saysEndpoints NewsProposed FDA budget sets Makary up to boost US biotechFierceBiotechWith Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engineFierceBiotechUS, UK regulators bolster medical device collaboration while lifting tariffsFierceBiotechZeto’s latest EEG device garners FDA 510(k) clearance for outpatient use
eLife 2026年3月17日

p53诱导的RNA结合蛋白ZMAT3抑制己糖激酶转录，以抑制人类癌细胞线粒体呼吸

p53诱导的RNA结合蛋白ZMAT3抑制己糖激酶转录，以抑制人类癌细胞线粒体呼吸

原文
暂时没有全文，请查看原始来源。

目录

59 全部